DOUGLAS RICHARD - 17 Jun 2026 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Reporting relationship: Director
Issuer ticker: MXCT
Reported as of: 17 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:26:42 UTC
Prior SEC filing: 11 Jun 2026
Next SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Maher Masoud, Attorney-in-Fact

Key filing fact

DOUGLAS RICHARD filed Form 4 for MAXCYTE, INC. (MXCT) on 22 Jun 2026.

Key facts

This page summarizes DOUGLAS RICHARD's Form 4 filing for MAXCYTE, INC. (MXCT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Jun 2026, 16:26.

Change

Previous filing in this sequence was filed on 11 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001021015 Primary reporting owner

DOUGLAS RICHARD

Relationship: Director
Address: C/O MAXCYTE, INC., 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE
Signature: /s/ Maher Masoud, Attorney-in-Fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MXCT transaction

Common Stock

Award

Transaction value
Shares: +30,421
Change %: +13%
Price: $0.000000^*
Shares after: 260,998
Date: 17 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MXCT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +49,579
Change %
Price: $0.000000^*
Shares after: 49,579
Date: 17 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 49,579
Exercise price: $1.13
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date.